Serina Therapeutics closes $5M second tranche of equity financing at 113% premium

Serina Therapeutics, Inc.

Received second $5M tranche of $10M equity financing from JuvVentures (UK) Limited.
Issued 500,000 shares at $10/share (113% premium to Jan 31 close of $4.70).
Issued warrants for 755,728 shares at $18.00 per share.
Funds to advance SER-252 (POZ-apomorphine) into Phase 1 trial in advanced Parkinson's in H2 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.